Bacchus Partners
Bacchus Partners is the general partner of a series of limited partnerships sourcing rare, fine and investment grade wines for long-term price appreciation and fulfilling the needs of new world buyers in the emerging wine markets of China, India, Russia, etc.
We believe this investment can be profitable in both the short and long-term and provide true diversification from more typical investments such as stocks and bonds. Rare and fine wine returns are generally unaffected by movements in equity and bond Markets and are a more effective hedge against equities than bonds, thereby increasing total portfolio returns while reducing overall risk. The wine market also tends to be less volatile than financial markets, is less susceptible to market downturns and adverse economic conditions and has proven to be an effective hedge against recession and inflation. Fine and rare wine demand is being further fueled by its worldwide status and its newfound discovery by US baby boomers.
The Fine Wine Appreciation Funds’ began operations in October 2008 and we manage an inventory of some of world's finest rare wines. To select these wines we use traditional portfolio management techniques coupled with an exceptional knowledge of the business. We believe our ability to exploit the multi-layered worldwide wine distribution system along with our disciplined purchasing approach will provide long-term capital growth for our partners.
Bacchus - the Partners
Michael R Wigley - Chairman & CEO - Since 1989, Mr. Wigley, an entrepreneur, has been president and chief executive officer of Great Plains Companies, Inc., a diversified holding company. Wigley has B.S. and B.C.E. degrees from the University of Minnesota, a M.S. degree from Stanford University and a M.B.A. degree from Harvard Business School. Wigley serves on the boards of several private and non-profit organizations.
Brian J Jackson - President & Treasurer - Mr. Jackson has a strong background in early stage medtech finance and analysis. Over the past 20 years, companies where he was an executive officer have raised over $35 million of growth capital in a variety of transactions including public, venture, private and bank financings. Jackson is a co-founder of St. Teresa Medical, a device firm and serves as Director and CFO. Also, Jackson serves as Vice President, CFO and Director of PepTx, a bio-pharmaceutical firm. Jackson is President of Bayside Capital, an executive financial consulting firm working with early stage medtech companies. Jackson holds a BSB from the University of Minnesota with a major in accounting and a double minor in finance and economics. Jackson is the co-inventor on one US Patent in cardiovascular technology.

|
Bacchus -
Roman God of Wine

Roman statue of Bacchus (Dionysus), God of Wine, circa 150 AD
(Prado, Madrid)
|